There were 1,155 press releases posted in the last 24 hours and 358,108 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Navigen Announces FDA Clearance of its IND Application to Initiate First-in-Human Studies for CPT31, a Novel, D-peptide HIV Entry Inhibitor

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image